Show simple item record

dc.contributor.authorCrandall, James E.
dc.contributor.authorSakai, Yasuo
dc.contributor.authorZhang, Jinhua
dc.contributor.authorKoul, Omanand
dc.contributor.authorMineur, Yann
dc.contributor.authorCrusio, Wim E.
dc.contributor.authorMcCaffery, Peter J.
dc.date2022-08-11T08:09:36.000
dc.date.accessioned2022-08-23T16:37:04Z
dc.date.available2022-08-23T16:37:04Z
dc.date.issued2004-03-31
dc.date.submitted2009-04-02
dc.identifier.citation<p>Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5111-6. Epub 2004 Mar 29. <a href="http://dx.doi.org/10.1073/pnas.0306336101">Link to article on publisher's site</a></p>
dc.identifier.issn0027-8424 (Print)
dc.identifier.doi10.1073/pnas.0306336101
dc.identifier.pmid15051884
dc.identifier.urihttp://hdl.handle.net/20.500.14038/38931
dc.description.abstractThe active component of the acne drug Accutane is 13-cis-retinoic acid (RA), and it is highly teratogenic for the developing central nervous system. Very little is known, however, regarding the effect of this drug on the adult brain. Regions of the brain that may be susceptible to RA are those that continue to generate new neurons. In the adult mouse, neurogenesis is maintained in the hippocampus and subventricular zone. This report demonstrates that a clinical dose (1 mg/kg/day) of 13-cis-RA in mice significantly reduces cell proliferation in the hippocampus and the subventricular zone, suppresses hippocampal neurogenesis, and severely disrupts capacity to learn a spatial radial maze task. The results demonstrate that the regions of the adult brain where cell proliferation is ongoing are highly sensitive to disruption by a clinical dose of 13-cis-RA.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=15051884&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC387382/
dc.subjectAnimals
dc.subjectCell Division
dc.subjectHippocampus
dc.subjectImmunohistochemistry
dc.subjectIsotretinoin
dc.subjectMaze Learning
dc.subjectMice
dc.subjectReceptors, Retinoic Acid
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.title13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice
dc.typeJournal Article
dc.source.journaltitleProceedings of the National Academy of Sciences of the United States of America
dc.source.volume101
dc.source.issue14
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/1762
dc.identifier.contextkey808527
html.description.abstract<p>The active component of the acne drug Accutane is 13-cis-retinoic acid (RA), and it is highly teratogenic for the developing central nervous system. Very little is known, however, regarding the effect of this drug on the adult brain. Regions of the brain that may be susceptible to RA are those that continue to generate new neurons. In the adult mouse, neurogenesis is maintained in the hippocampus and subventricular zone. This report demonstrates that a clinical dose (1 mg/kg/day) of 13-cis-RA in mice significantly reduces cell proliferation in the hippocampus and the subventricular zone, suppresses hippocampal neurogenesis, and severely disrupts capacity to learn a spatial radial maze task. The results demonstrate that the regions of the adult brain where cell proliferation is ongoing are highly sensitive to disruption by a clinical dose of 13-cis-RA.</p>
dc.identifier.submissionpathoapubs/1762
dc.contributor.departmentDepartment of Psychiatry
dc.contributor.departmentBrudnick Neuropsychiatric Research Institute
dc.contributor.departmentE. K. Shriver Center
dc.source.pages5111-6


This item appears in the following Collection(s)

Show simple item record